February 26, 2020 / 12:49 PM / in a month

BRIEF-Axcella Completes Enrollment Of Subjects In Axa1665-002 Study

Feb 26 (Reuters) - Axcella Health Inc:

* AXCELLA COMPLETES ENROLLMENT OF SUBJECTS IN AXA1665-002 STUDY

* AXCELLA - TOP-LINE DATA FOR AXA1665-002 STUDY EXPECTED IN MID-2020

* AXCELLA - IND SUBMISSION FOR OVERT HEPATIC ENCEPHALOPATHY, INITIATION OF POTENTIAL REGISTRATIONAL PHASE 2B/3 CLINICAL TRIAL PLANNED FOR H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below